The Global Interventional Neurology Market is Expected to Grow at a CAGR of 7% from 2010 through 2017
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Interventional Neurology - Global Pipeline Analysis,Competitive Landscape and Market Forecasts to 2017
The Global Interventional Neurology Market is Expected to Grow at a CAGR of 7% from 2010 through 2017 The global interventional neurology market is forecast to grow from $827.2m in 2010 to $1356m in 2017 at a Compound Annual Growth Rate (CAGR) of 7%. The market expects to grow due to the increasing incidence of aneurysm disease globally. The market is also expected to be driven by increasing treatment options, the sophistication of the procedures available for treatment and improving imaging techniques for the early detection of aneurysms. Embolic Systems are the Largest Market Segment The embolic systems market is the largest segment in terms of market size and accounted for almost 44% of total revenue generated in 2010. Navigational systems, neurovascular stents and aneurysm clips were the other three segments of the interventional neurology market in 2010. The embolic systems segment will continue to witness high growth and remain the largest segment. The global market for embolic systems is forecast to grow from $370.3m in 2010 to about $639.5m in 2017, at a CAGR of 8%. Development in endovascular treatment procedures, such as embolic coiling, liquid embolic systems and imaging techniques, will drive the global interventional neurology market. The US is the Biggest Market for Interventional Neurology
The US market for interventional neurology was valued at $339.3m in 2010 and is forecast to grow at a CAGR of 8% to reach $566m in 2017. The US is the biggest market in the sector, making up 41% of the global interventional neurology market in 2010. In the US, demand for interventional neurology products is mainly driven by the development of embolization procedures. The market is expected to be driven by the increasing awareness about aneurysm causing diseases and treatment procedures. In the US, navigational systems were the largest market segment, valued at $154.1m, in 2010. In 2017, the trend in the market will change and the embolic systems market will grow at a CAGR of 9% to be the largest segment, reaching $257m. Shift to Minimally Invasive Treatment is Driving the Interventional Neurology Market The market is shifting towards minimally invasive treatment and away from surgical treatment options. This is increasing the market value of the endovascular treatment option for aneurysms. Instead of open operations, this minimally invasive technique uses X-ray imaging, catheters, and various embolic systems and neurovascular For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Interventional-Neurology-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report
stents to treat diseases of the blood vessels of the brain and spine. The advantages of coil treatment include the speed of procedure and the use of an endovascular approach rather than craniotomy. This shift is also increasing treatment options for patients with multiple aneurysms, which can now be treated at the same time. Use of Interventional Neurology Products for Treating Other Diseases is a Emerging Trend in the Market Interventional neurology products are not only used for treating aneurysms. Many products can be used for treating diseases such as ischemic stroke, brain arteriovenous malformation (AVM) and dural arteriovenous fistula and vasospasm, amongst others. Many companies have products in the pipeline which can be used for aneurysms as well as for ischemic strokes. The second target disease for using interventional neurology products is AVM. The embolization procedure is helpful when performed before surgery or radiation for AVM. It is useful in reducing bleeding during surgery and also helps in reducing the size of the AVM to be radiated. Boston Scientific, DePuy and Covidien were the Leading Players in the Interventional Neurology Market in 2010 Boston Scientific, Johnson & Johnson, Covidien plc and Terumo were the leading companies in the interventional neurology market in 2010, accounting for 94% of the market. Boston Scientific was the market leader with a 31% share. However, it is expected that the competitive landscape will change as Boston recently sold all of its neurovascular products to Stryker.
The global market for interventional neurology was fragmented in 2010 due to the presence of a number of small players. However, a large number of acquisitions made by the market leaders is resulting in the consolidation of the market GlobalData’s new report, “Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global interventional neurology market. The report provides market landscape, competitive landscape and market trends information on the interventional neurology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings For further details, please click or add the below link to your browser: http://www.globaldata.com/reportstore/Report.aspx?ID=Interventional-Neurology-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report Visit our report store: http://www.globaldata.com
For more details contact: firstname.lastname@example.org North America: +1 646 395 5477 Europe: +44 207 753 4299 +44 1204 543 533 Asia Pacific: +91 40 6616 6782